Healthcare -
Biotechnology - NASDAQ - US
$ 6.7
-1.04 %
$ 60.6 M
Market Cap
-167.0
P/E
ICCC - SHORT-TERM DEBT
Short-term Debt ICCC - ImmuCell Corporation
1.5 M
LAST VALUE
18.24%
2 YEAR CAGR
3.27%
5 YEAR CAGR
25.84%
10 YEAR CAGR